Chapter 1: Cosmogate
“We don’t predict the future. We invoice it.”
My name is Professor John Collins. Welcome to Cosmogate orientation tour. Today, in the final days of the year 2042, I have the privilege of introducing the nation’s top students to a company that has revolutionized the modern world—a company where I proudly serve as the Head of Bioengineering.
I’ve prepared a comprehensive overview to help you understand Cosmogate, especially its groundbreaking work in health and biological innovation. This year, Cosmogate once again stunned the world and was declared the most powerful corporation on the planet. Years ago, it began its extraterrestrial ventures with two ambitious undertakings: Project Sophia and Project Hermes. Through these, it succeeded in extracting rare materials from our solar system, laying the foundation for what we now call Bio-alloy—a futuristic meta-material capable of controlled quantum and biochemical reactions.
This material was unlike anything the world had seen. Bio-alloy could be programmed at the molecular level and integrated into living organisms without triggering immune responses. We theorize that, due to its adaptive nature, Bio-alloy behaves much like internal organs within a host body, forming a stable link with synaptic receptors. It echoes the breakthroughs of early gene-editing systems—except with vastly more precision and potential.
Some claim this material can even influence the perception of time—slowing it down for the host—by reducing serotonin levels, much like how cortisol affects the brain. Cosmogate’s research team extracted four elements—codenamed X-element Alpha, Gamma, and Zeta—from beyond Earth’s orbit to drive several post-scientific projects, including one of our most revolutionary: the Omni-chip.
The Omni-chip is a nano-gel implant designed to interface directly with neural networks. Our first human trial was conducted on one of Cosmogate’s own vice presidents, who had been diagnosed with early-stage Alzheimer’s. After implantation in the hippocampus, not only did the patient recover memory function rapidly, but the cortex became resilient to further neurodegeneration. Even the amygdala showed signs of regeneration. The chip stores massive amounts of biodata—biological information—categorized much like synthetic DNA strands. This chip essentially transformed the human brain into a biological computer, boosting memory retention and data processing. It marked the beginning of the end for neurological diseases.
Subsequent designs of the Omni-chip aimed to restore motor function in paraplegics, reverse blindness, treat speech disorders, and potentially cure neurodegenerative diseases like MS and ALS. Early tests were so successful that, despite their high cost, the chips are already set for elite-tier production.
But the Omni-chip is only the beginning.
Another monumental project enabled by Bio-alloy is the Meta-vaccine—a biological chip capable of instantly transmitting pathogen data to the immune system. It essentially arms the body before any disease can spread. This was previously achieved in cancer treatment, where T-cells were stimulated using nano-capsules containing encoded viral signatures—particularly effective in treating lymphatic cancers.
Here’s how the Meta-vaccine works: upon detection of a foreign agent, the chip activates a “friend or foe” system, scanning and decoding the pathogen’s genome in real time. What previously took scientists days in a lab—genome extraction, mRNA synthesis, protein translation—is now done in a few hours. It records every pathogen it encounters, making the body immune to repeat infections, and can generate immune responses to new pathogens on first contact. This advancement could become the single greatest milestone in immunology and bioinformatics.
But why did we develop these chips in the first place?
It all began with a pandemic years ago—a highly infectious disease that disproportionately targeted the elderly and immunocompromised. Many speculated the virus was genetically engineered with a singular purpose: population reduction. Experts noted that it was curiously selective, eliminating those considered “non-contributing” by the standards of the emerging world order—those who consumed more than they produced. In underdeveloped countries, the economic cost of poverty was rising. Some believed mass culling was seen as a more efficient solution.
Meanwhile, in the developed world, people were willing to sell everything for access to the vaccine. The leading theory? Pharmaceutical companies had created the vaccine long before the outbreak. But in order to profit from it, they needed global panic. So, they waited. And watched.
One student raised this concern to me. I responded, “That’s a theory—but I work with evidence.” Still, the numbers were staggering. Within just sixteen months, over 70% of Earth’s population had been infected. More than 12% died. Global fear reached medieval levels. The very notion of public health was questioned, and hope seemed like a myth.
And now, Cosmogate.
Some believe Cosmogate employs the very scientists who designed that virus. Yet today, those same minds are working tirelessly to eradicate microbial diseases. The most expensive biomedical project in human history is underway. A project that may one day achieve what pharmaceutical companies delayed for decades. A project so far-reaching that all modern conspiracy theories now point back to Cosmogate.
Another student asked, “Even if Cosmogate promises hope, won’t the astronomical price of Bio-alloy ensure that only the rich benefit?”
To that, I replied, “The only limiting factor right now is the scarcity of the raw material, especially X-element Zeta. If we ever hope to mass-produce Bio-alloy, we must discover a viable substitute.”
No one knows whether Cosmogate truly works for the greater good—or merely for the machinery of capitalism. The company now claims that immortals already walk among us. According to their latest statements, Cosmogate will soon eliminate aging entirely by preserving DNA telomeres and preventing cellular shock. They intend to make death by old age obsolete.
They seem to have considered every angle.
People who can no longer die—not by disease, nor by time. Power and wealth now come with longevity. And even if that power is in the hands of destructive ideologies—those who control the New World Order—those ideas may live forever, simply because their hosts never die.
And for the first time, death itself is no longer the equalizer.
